Anti-G has been reported as a possible cause of hemolytic disease of the fetus and newborn (HDFN), either independently or in association with anti-D, anti-C or both. The antibody mimics the pattern of anti-C and anti-D reactivity in the identification panel and is often present along with either or both of these antibodies. The differentiation of anti-D, -C and-G in routine pretransfusion workup is particularly essential in antenatal cases. We report two antenatal cases where anti-G was identified on advanced immunohematological workup, in addition to other alloantibodies.
Introduction Introduction
The "Rhesus G" (Rh) antigen was fi rst described by Allen and Tippet in 1958 [1] and anti-G has been reported as a possible cause of hemolytic disease of fetus and newborn (HDFN), either independently or in association with anti-D, anti-C or both. [2, 3] The antibody mimics the pattern of anti-C and anti-D reactivity in the identifi cation panel and is often present along with either or both of these antibodies. [1] The differentiation of anti-D, -C and G in routine pretransfusion workup is particularly essential in antenatal cases. In the alloimmunized pregnant women showing a reactivity pattern of anti-C plus anti-D, there might be an underlying anti-G causing HDFN either alone or in addition to these antibodies. [4] [5] [6] [7] This complex serological condition often accounts for medical dilemmas like anti-D like picture in the maternal serum in spite of Rh D prophylaxis at the time of previous pregnancy or HDFN in a child due to anti-D when the father is D negative. The antibodies in such cases could actually be anti-G or anti-G+C. The former can often be mistaken as failure of Rh D prophylaxis. However the woman still stands a chance of getting immunized against anti-D and should, therefore, receive Rh immunoglobulin (RhIG). [2, [4] [5] [6] [7] We report here two such cases of HDFN due to multiple alloantibodies including anti-G.
Case Reports Case Reports st intrauterine transfusion (IUT) was done using Group O Rh (D) negative (ccee K-) leukoreduced, irradiated packed red cells (PRC) with a hematocrit of 80%. Before starting the IUT, a fetal blood sample was sent for blood grouping, phenotyping, and direct antiglobulin test (DAT) and complete blood count. Cell group of the fetus was O Rh (D) Positive and phenotype was Ccee K-. DAT was strongly positive. IUT was repeated at 32 weeks of gestation. In view of falling of hematocrit of 1% per day elective caesarean section was done at 35 weeks. The neonate had a body weight of 2.9 kg with an APGAR scoring of 7 and 8 at 1 and 5 min, respectively. On day 1 the hemoglobin (Hb) was 10.5 g/dL and total bilirubin was 4.7 mg/dL with direct bilirubin being 0.7 mg/dL. Cord blood obtained also revealed a positive DAT. The neonate received one exchange transfusion with Group O Rh (D) negative blood (ccee K-) and was kept on phototherapy. The direct bilirubin level was all through maintained between 0.2 and 0.7 mg/dL supporting absence of obstructive jaundice. With phototherapy, the total bilirubin was maintained at <6 mg/dL and eventually tapered, and the baby was discharged on day 26 in healthy condition. [5] In both the cases, the patients' plasma was adsorbed onto fi cin treated r'r' cells fi ve times to adsorb anti-C and/or anti-G to exhaustion. The adsorbed plasma was then tested against r'r' and R 0 r cells showing negative reaction and strength of +4 respectively, confi rming complete adsorption of anti-C and/or anti-G and presence of anti-D. Eluate was prepared using Gamma ELU-KIT™ II, Immucor, from the fi rst adsorbing aliquot of r'r' cells and tested with R 0 r and r'r' (red blood cells) RBCs which gave +4 and +3 reaction strengths respectively, confi rming presence of anti-G. The eluate was then adsorbed on to fi cin treated R 0 r cells fi ve times to adsorb out anti-G. This adsorbed plasma was again tested with R 0 r cells which gave a negative reaction confi rming complete adsorption of anti-G. This adsorbed plasma was again tested with R 0 r cells, which gave a negative reaction confi rming complete adsorption of anti-G. This was then tested with r'r' cells for presence of anti-C which gave +4 reaction in case 1 and negative reaction in case 2 confi rming presence of anti-C in case 1 and its absence in case 2. From the fi rst aliquot of R 0 r cells elution was done and checked with r'r' RBCs which gave +4 reaction strength re-confi rming the presence of anti-G in both the cases.
Discussion Discussion
Rhesus (D) alloimmunization was largely recognized as the cause of immune HDFN until 1960s. Antenatal interventions like routine prophylactic RhIG given to D negative women has reduced alloimmunization rate by nearly 90%. However, cases of HDFN resulting from alloimmunization are still reported. [8] The most frequent alloantibodies besides anti-D that are identifi ed in the sera of these patients are directed against: Rh antigens (anti-E, anti-C, anti-c), Kell antigens (anti-K), Duffy antigens (anti-Fy a ), Kidd antigens (anti-Jk a ), and MNSs antigens. [8] This, to the best of our knowledge is the fi rst report of anti-G antibody from India. Both the cases reported here showed clinical features of severe HDFN. Since anti-D has been independently identifi ed in both the patients, the HDFN can be largely attributed to its presence. However, advanced investigations have revealed the presence of anti-G in both the cases, which could be contributing to the severity of HDFN. In the second case reported, no anti-C antibody was fi nally identifi ed and the anti-C like picture observed in the identifi cation panel was actually due to the presence of anti-G, which was mimicking the anti D + C picture.
The report, therefore, highlights the importance of performing advanced investigations in order to accurately characterize the immunizing antibodies especially in pregnant women, where it is of paramount importance to confi rm the presence or absence of anti-D. The presence of anti-D excludes the need for the administration of prophylactic anti-D immunoglobulin. In addition, the exclusion of the presence of anti-D in samples from D-negative women with D-negative partners or from D-negative recipients of D-negative blood components can avoid potential social or medico-legal complications. [2] In the absence of advanced testing it is likely that anti-G antibodies are being under diagnosed in our country.
Note Note
Due to nonavailability of the rare r G r cells, a direct evidence of anti-G could not be established. However, double adsorption technique has been widely used and reported in literature as highly supportive of the presence of anti-G. [9] 
